Local News
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease - TTUHSC: DAILY DOSE
A common cancer drug might also slow Alzheimer's progression, thanks to research happening right here at TTUHSC.
If this study proves successful, our medical school could deliver profound new hope for families grappling with Alzheimer's across the entire South Plains. This debilitating disease touches countless homes, from the historic buildings in the Depot District to the newer developments north of Loop 289. Breakthroughs like this elevate TTUHSC's national profile, potentially attracting more research grants and top scientific talent to Lubbock, further solidifying our city as a medical hub. It could lead to tangible treatment options becoming available for local patients seeking care near University Medical Center, easing burdens on caregivers and individuals.
Uncovering a new application for an already approved medication might significantly accelerate the availability of desperately needed therapies for millions.
Common questions
What is TTUHSC researching about Alzheimer's?
- TTUHSC researchers in Lubbock are investigating if a common cancer drug, lenalidomide, can slow the progression of early-stage Alzheimer's disease. Dr. Boris Decourt is leading this Phase II clinical trial, building on promising earlier findings from a Phase I study.
Who is leading this Alzheimer's research at TTUHSC?
- Dr. Boris Decourt, director of the Texas Tech University Health Sciences Center's neurodegeneration lab, is leading this important research. He is collaborating with St. Joseph's Hospital and Medical Center in Phoenix on the new Phase II clinical trial.
Why does this research matter to Lubbock residents?
- This research by Lubbock's TTUHSC could offer profound new hope for families across the South Plains grappling with Alzheimer's disease. A successful study might deliver new treatment options for this debilitating condition from right here in West Texas.
Stay in the loop
Weekly Lubbock news, deals, and events. Free.